Epsilogen

Epsilogen

Pre-clinical
London, United KingdomFounded 2018epsilogen.com

Our unique and proprietary expertise is focused on the discovery and development of immunoglobulin IgE, IgA and IgG-based therapeutics. The immune system relies upon the differential effector functions of the various antibody isotypes to generate the best immune response to a given challenge. Similarly, we match the attributes of each isotype to a given cancer to optimize performance. We have also combined different isotypes into single antibody molecules to broaden and strengthen their anti-...

Founded
2018
Focus
AntibodiesBiologics

About

Our unique and proprietary expertise is focused on the discovery and development of immunoglobulin IgE, IgA and IgG-based therapeutics. The immune system relies upon the differential effector functions of the various antibody isotypes to generate the best immune response to a given challenge. Similarly, we match the attributes of each isotype to a given cancer to optimize performance. We have also combined different isotypes into single antibody molecules to broaden and strengthen their anti-...

Funding History

2

Total raised: $20.8M

Series A$16.5MGilde HealthcareJun 15, 2021
Seed$4.3MCancer Research UKJun 15, 2019

Company Info

TypePrivate
Founded2018
LocationLondon, United Kingdom
StagePre-clinical
SIMILAR COMPANIES
Abbexa
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Accentus Medical
Pre-clinical · Oxford
AbOliGo
AbOliGo
Pre-clinical · London
Bigespas
Bigespas
Pre-clinical · London
Actimed Therapeutics
Actimed Therapeutics
Pre-clinical · London
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile